Manufacturer record
Maxtar Bio-Genics: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Maxtar Bio-Genics (Himachal Pradesh) were declared Not of Standard Quality between August 2022 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Maxtar Bio-Genics in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cipex-500 (Ciprofloxacin Tabets I.P) | MUTAD23 01Mfg 2023-06 · Exp 2026-05 | Test for Dissolution onlyDissolution | State Lab KarnatakaState lab | Dec 2024 |
| Fexofenadine Hydrochloride Tablets IP 120 mg | MP9AA2303Mfg 2023-07 · Exp 2026-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2024 |
| Fexofenadine Hydrochloride Tablets IP 120 mg | MP9AA2303 (Two different samples received with same batch number)Mfg 2023-07 · Exp 2026-06 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2024 |
| Albendazole Tablets IP | MS1AO22 01Mfg 2022-07 · Exp 2025-06 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jun 2024 |
| Albendazole Tablets IP | MS1AO2205Mfg 2022-10 · Exp 2025-09 | Dissolution testDissolution | RDTL ChandigarhState lab | Nov 2023 |
| ALBENDAZOLE TABLETS I.P. | MS4AI2301Mfg 2023-01 · Exp 2025-12 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Oct 2023 |
| Telmisartan and Amlodipine Tablets IP | MS1AJ2302Mfg 2023-02 · Exp 2026-01 | Assay of Amlodipine Besilate equivalent to AmlodipineAssay | RDTL ChandigarhState lab | Sep 2023 |
| Albendazole Tablets IP | MS4AI2202Mfg 2022-09 · Exp 2025-08 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2023 |
| Vitamin D3 Chewable Tablets 60,000 IU | MUTBC2101Mfg 2021-07 · Exp 2023-06 | DescriptionDescription | RDTL GuwahatiState lab | Aug 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.